Baird starts ResMed at outperform, cites growing sleep apnea market Sep. 24, 2024 2:18 PM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Seeking Alpha
Baird said that while ResMed won't “have the competitor-recall-related share gains/pricing tailwinds at their back,” the company should deliver “MSD-HSD revenue/LDD-mid-teens EPS growth ahead as rising OSA prevalence drives MSD device growth and recurring HSD growth revenue streams augment." The investment firm added that while ResMed's revenue numbers “appear achievable, the timing and magnitude of likely GLP-1 impacts remain an overhang.” Baird added that the stock appears to be “priced to perfection” heading into the company's analyst day on Sept. 30. The firm set its price target for the stock at $280. Recommended For You More Trending News Recommended For You More Trending News About RMD Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed Inc. (NYSE: RMD) was upgraded by analysts at Baird R W to a "strong-buy" rating.MarketBeat
- ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Bank of America Co. from $240.00 to $270.00. They now have a "buy" rating on the stock.MarketBeat
- ResMed (NYSE:RMD) Eyes Growth with Board Expansion and Solid Earnings Despite Freight Cost Challenges [Yahoo! Finance]Yahoo! Finance
- Pottery Barn Launches Nightstand Designed To Fit Your CPAP Machine [Forbes]Forbes
- ResMed Inc. (NYSE: RMD) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $280.00 price target on the stock.MarketBeat
RMD
Earnings
- 8/1/24 - Beat
RMD
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/10/24 - Form 4
- RMD's page on the SEC website